NovaBay (NYSE:NBY) said it has accepted a revised offer from PRN Physician Recommended Nutriceuticals that increases the base purchase price of its Avenova eyecare business to $11.5M from $9.5M. In ...
On Tuesday, NovaBay Pharmaceuticals Inc (NBY) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.10 or 18.18% from the prior close of $0.55. The stock opened ...
I am writing to you because I am tired of hearing complaints against our health system. My husband (elderly) was recently in Rotorua Hospital for almost three weeks. He was extremely ill on ...